| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 406GR1485Z |
| InChI Key | FBCQEUMZZNVQKD-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H13F2NO3 |
| Molecular Weight | 341.31 |
| AlogP | 4.35 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 60.77 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 25.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Estrogen receptor alpha agonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 1
|
- | - | - | 21.7-21.7 | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 2
|
- | - | - | 15.2-15.2 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 938067-78-8 |
| ChEMBL | CHEMBL3545017 |
| DrugBank | DB14969 |
| FDA SRS | 406GR1485Z |
| PubChem | 46861578 |
| SureChEMBL | SCHEMBL2112794 |
| ZINC | ZINC000096173894 |